Where I see patients (3)
My reviews
Selected research
-
Tumor heterogeneity underlies clinical outcome and MEK inhibitor response in somatic NF1-mutant glioblastoma.
JCI insight
-
Novel radiotherapy target definition using AI-driven predictions of glioblastoma recurrence from metabolic and diffusion MRI.
NPJ digital medicine
-
Consolidation of Metastatic Sites in Pediatric Sarcoma: Evidence and Opportunities.
International journal of radiation oncology, biology, physics
Clinical trials
Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meni...
Percentage of patients who are progression-free at the landmark of 12 months from start of treatment based on the target lesion(s) that are receiving radiation treatment will be reported. Tumor progression will be assessed using I...
Recruiting
Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastase...
PFS is defined as time from craniospinal irradiation (CSI) to CNS disease progression or death. CNS-PFS will be summarized using Kaplan-Meier methodology. Median, 95% confidence interval (CI) and Kaplan-Meier plot will be provided...
Recruiting
4.9